Remarks of the Acting FDA Commissioner: FDLI's 48th annual conference.
Crawford
Lester M
LM
Food and Drug Administration (FDA), Rockville, MD, USA.
D003257:Consumer Product Safety; D016208:Databases, Factual; D018795:Device Approval; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence; D005544:Forecasting; D007255:Information Services; D015969:National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; D011358:Product Surveillance, Postmarketing; D012637:Security Measures; D013673:Technology Assessment, Biomedical / Q000331:legislation & jurisprudence; D023481:Terrorism / Q000517:prevention & control; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration / Q000639:trends